1993
DOI: 10.1001/archinte.1993.00410010097008
|View full text |Cite
|
Sign up to set email alerts
|

Decreased Risk of Stroke Among Postmenopausal Hormone Users

Abstract: The results suggest that postmenopausal hormone use is associated with a decrease in risk of stroke incidence and mortality in white postmenopausal women.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0
1

Year Published

1996
1996
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 186 publications
(21 citation statements)
references
References 27 publications
0
20
0
1
Order By: Relevance
“…26,27 These observations have been interpreted as probable evidence that female reproductive hormones provide vascular protection in ischemic heart disease and stroke. However, it is unclear whether estrogens per se are critical for modulating the risk of stroke or which mechanism provides protection.…”
Section: Discussionmentioning
confidence: 97%
“…26,27 These observations have been interpreted as probable evidence that female reproductive hormones provide vascular protection in ischemic heart disease and stroke. However, it is unclear whether estrogens per se are critical for modulating the risk of stroke or which mechanism provides protection.…”
Section: Discussionmentioning
confidence: 97%
“…226 In other studies, the relative risk of stroke among hormone replacement therapy users varied from 0.23 to 1.46, with the relative risk of fatal stroke ranging from 0.30 to 1.40. 170,192,[227][228][229][230][231][232][233][234][235][236][237][238][239] A review indicated a neutral effect of postmenopausal hormone replacement therapy, with a relative risk of 0.96. 240 However, the studies conducted to date have had methodological limitations.…”
Section: Hormone Replacement Therapymentioning
confidence: 99%
“…Postmenopausal estrogen use has been associated with increased 22,26 and decreased 27,28 risks and no net benefit for stroke prevention. 29 -32 The NIH-sponsored Women's Estrogen for Stroke Trial (WEST) 33 compared 17␤-estradiol (1 mg/d) to placebo in postmenopausal women with a recent history of transient ischemic attack or ischemic stroke.…”
Section: Secondary Prevention After Strokementioning
confidence: 99%